DISEASE INDICATIONS: Colorectal Cancer

MANUFACTURER: Les Laboratoires Servier

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Lonsurf (trifluridine/tipiracil) is a chemotherapy medication that has been approved by the Food and Drug Administration (FDA) in the USA, European Medical Agency (EMA) in the European Union, and Therapeutic Goods Administration (TGA) in Australia for the treatment of metastatic colorectal cancer in previously treated patients.